
Acumen Pharmaceuticals fell 88.3% from $1.66 to $0.19, behind the S&P 500's +10.6%. Its worst day was Oct 30 (−90.8%), and its low came Nov 18 at $0.19.
Nov 18, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Acumen Pharmaceuticals shares rose 30.8%, while the S&P 500 rose 0.4%.
+30.8%, the year's best day · S&P 500 +0.4%
Acumen Pharmaceuticals closed at its highest level of the year, 103.0% above where the year started.
Story events cover the past 12 months · Times ET
+0.3% · S&P 500 −0.1%
EPS of $-0.41 beat the $-0.53 estimate on $0.00 revenue.
−3.0% · S&P 500 −1.8%
EPS of $-0.33 beat the $-0.49 estimate on $0.00 revenue.
−3.5% · S&P 500 −0.2%
EPS of $-0.45 missed the $-0.40 estimate on $0.00 revenue.
+1.6% · S&P 500 +0.3%
EPS of $-0.35 beat the $-0.40 estimate on $0.00 revenue.
+14.6% · S&P 500 +0.7%
Where it ended: a close of $0.19 on Nov 18, 2026.
Nothing in the past 12 months.
All ABOS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ABOS and SPY from Benzinga historical bars. Not investment advice.